Patient Square Capital has led a $145m (£104m) funding round for Apollo Therapeutics, a UK-based biopharmaceutical company, and acquired a controlling stake.
Calucem reports a turnover of EUR 58m, with an EBITDA of EUR 16m
Should Apex make a firm offer, Cinven would have to significantly up its own bid for the fund administrator
Third exit announced by Lonsdale this year, and the second from its 2016 fund
Paris-based private equity firm is exploring options around a dual-track process